Moolec Science SA Expands U.S. Safflower Acreage and Secures Regulatory Approval in Argentina, Enhancing Global Protein Solutions Portfolio

Reuters09-11
Moolec Science SA Expands U.S. Safflower Acreage and Secures Regulatory Approval in Argentina, Enhancing Global Protein Solutions Portfolio

Moolec Science SA, an innovation-driven company specializing in engineering plants and microbes for scalable protein solutions, has announced significant advancements in its operations. The company has received regulatory approval in Argentina for its safflower GLASO technology, which is expected to enhance its production capabilities. In the United States, Moolec is doubling the acreage for its safflower production season, aiming to increase commercial inventory and meet growing demand in the pet food and human nutrition industries. Additionally, the company has strengthened its leadership team by appointing Valeria Falottico as the new Chief Financial Officer, following her extensive experience in financial and compliance reporting. These developments underscore Moolec's commitment to delivering high-quality protein solutions and expanding its technological base globally.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moolec Science SA published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1071657) on September 11, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment